MedPath

Model 4296 Left Ventricular (LV) Lead Chronic Performance Study

Completed
Conditions
Heart Failure
Registration Number
NCT01361672
Lead Sponsor
Medtronic
Brief Summary

Lead survivability will be summarized.

Detailed Description

The purpose of this study is to evaluate long-term performance of the 4296 LV Lead. This evaluation is based on the number of lead-related complications occurring during the study compared to the number of leads enrolled in the study. The leads will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the Model 4296 LV Lead. This study is conducted within Medtronic's post-market surveillance platform.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1140
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Model 4296 LV Lead-related complication rate5 years

To demonstrate that the Model 4296 lead-related complication-free probability

Secondary Outcome Measures
NameTimeMethod
Number of fractures with and without loss of function5 years

To characterize fractures with and without loss of function

Types of lead-related adverse device effects5 years

To summarize all lead related adverse events

Percent of subjects with changes in electrode programming5 years

To characterize any changes in electrical programming

Bipolar electrical performance at 1 year1 year

To summarize bipolar electrical performance at one year post implant

Bipolar pacing impedance1 year

To characterize threshold measurements and impedance for both conductors

Bipolar pacing capture threshold1 year

To characterize standard bipolar pacing voltage thresholds

© Copyright 2025. All Rights Reserved by MedPath